Underlying the Mechanisms of Doxorubicin-Induced Acute Cardiotoxicity: Oxidative Stress and Cell Death

被引:178
|
作者
Kong, Chun-Yan [1 ,2 ]
Guo, Zhen [1 ,2 ]
Song, Peng [1 ,2 ]
Zhang, Xin [1 ,2 ]
Yuan, Yu-Pei [1 ,2 ]
Teng, Teng [1 ,2 ]
Yan, Ling [1 ,2 ]
Tang, Qi-Zhu [1 ,2 ]
机构
[1] Wuhan Univ, Dept Cardiol, Renmin Hosp, Wuhan 430060, Peoples R China
[2] Hubei Key Lab Metab & Chron Dis, Wuhan 430060, Peoples R China
来源
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2022年 / 18卷 / 02期
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Doxorubicin; cardiotoxicity; oxidative stress; cell death; MANGANESE SUPEROXIDE-DISMUTASE; INDUCED CARDIAC DYSFUNCTION; INDUCED CARDIOMYOPATHY; NITRIC-OXIDE; ATTENUATES CARDIOTOXICITY; INDUCED HEART; MOUSE HEART; HUMAN SIR2; MITOCHONDRIAL; PROTECTS;
D O I
10.7150/ijbs.65258
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer is a destructive disease that causes high levels of morbidity and mortality. Doxorubicin (DOX) is a highly efficient antineoplastic chemotherapeutic drug, but its use places survivors at risk for cardiotoxicity. Many studies have demonstrated that multiple factors are involved in DOX-induced acute cardiotoxicity. Among them, oxidative stress and cell death predominate. In this review, we provide a comprehensive overview of the mechanisms underlying the source and effect of free radicals and dependent cell death pathways induced by DOX. Hence, we attempt to explain the cellular mechanisms of oxidative stress and cell death that elicit acute cardiotoxicity and provide new insights for researchers to discover potential therapeutic strategies to prevent or reverse doxorubicin-induced cardiotoxicity.
引用
收藏
页码:760 / 770
页数:11
相关论文
共 50 条
  • [1] Oxidative stress injury in doxorubicin-induced cardiotoxicity
    Mei Songbo
    Hong Lang
    Cai Xinyong
    Xiao Bin
    Zhang Ping
    Shao Liang
    TOXICOLOGY LETTERS, 2019, 307 : 41 - 48
  • [2] Role of Oxidative Stress and Inflammation in Doxorubicin-Induced Cardiotoxicity: A Brief Account
    Vitale, Roberta
    Marzocco, Stefania
    Popolo, Ada
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [3] Protection by pitavastatin from doxorubicin-induced acute cardiotoxicity through suppression of oxidative stress
    Xin, Yan-fei
    Han, Bin
    Zhou, Guo-liang
    You, Zhen-qiang
    Gu, Li-qiang
    Gao, Hai-yan
    Zhang, Sheng
    Yu, Jian
    Xuan, Yao-xian
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 74 - 74
  • [4] Doxorubicin-induced oxidative stress injury: The protective effect of kumiss on cardiotoxicity
    Yilmaz, Seval
    Kaya, Emre
    Yonar, Harun
    Mendil, Ali Sefa
    JOURNAL OF THE HELLENIC VETERINARY MEDICAL SOCIETY, 2022, 73 (03): : 4545 - 4558
  • [5] Regulated cell death pathways in doxorubicin-induced cardiotoxicity
    Christidi, Effimia
    Brunham, Liam R.
    CELL DEATH & DISEASE, 2021, 12 (04)
  • [6] Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosis
    Zhang, Jianping
    Cui, Lijing
    Han, Xue
    Zhang, Yuanyuan
    Zhang, Xuan
    Chu, Xi
    Zhang, Fenghua
    Zhang, Ying
    Chu, Li
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 93 : 1253 - 1260
  • [7] The beneficial role of exercise in preventing doxorubicin-induced cardiotoxicity
    Gaytan, Samantha L.
    Lawan, Ahmed
    Chang, Jongwha
    Nurunnabi, Md
    Bajpeyi, Sudip
    Boyle, Jason B.
    Han, Sung Min
    Min, Kisuk
    FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [8] Didymin attenuates doxorubicin-induced cardiotoxicity by inhibiting oxidative stress
    Chen, Rongchang
    Sun, Guibo
    Xu, Lijiao
    Zhang, Xu
    Zeng, Wenying
    Sun, Xiaobo
    CHINESE HERBAL MEDICINES, 2022, 14 (01) : 70 - 78
  • [9] Protective effect of thymoquinone against doxorubicin-induced cardiotoxicity and the underlying mechanism
    Chen, Yi
    Luo, Wei
    Wu, Yanqing
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2025, 495
  • [10] Cardiomyocyte death in doxorubicin-induced cardiotoxicity
    Zhang, Yi-Wei
    Shi, Jianjian
    Li, Yuan-Jian
    Wei, Lei
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2009, 57 (06) : 435 - 445